Ptc Therapeutics, Inc. Earnings logo

PTCT

Ptc Therapeutics, Inc. Earnings

$52.59

Earnings Summary

Revenue
$213.17Mn
Net Profits
$-65.89Mn
Net Profit Margins
-30.91%
Highlights
Revenue:

Ptc Therapeutics, Inc.’s revenue fell -30.58% since last year same period to $213.17Mn in the Q4 2024. On a quarterly growth basis, Ptc Therapeutics, Inc. has generated 8.33% jump in its revenue since last 3-months.

Net Profits:

Ptc Therapeutics, Inc.’s net profit jumped 57.71% since last year same period to $-65.89Mn in the Q4 2024. On a quarterly growth basis, Ptc Therapeutics, Inc. has generated 38.22% jump in its net profits since last 3-months.

Net Profit Margins:

Ptc Therapeutics, Inc.’s net profit margin jumped 39.08% since last year same period to -30.91% in the Q4 2024. On a quarterly growth basis, Ptc Therapeutics, Inc. has generated 42.97% jump in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Ptc Therapeutics, Inc. post its latest quarter earnings
EPS Estimate Current Quarter
-0.65
EPS Estimate Current Year
-0.65
Highlights
EPS Estimate Current Quarter:

Ptc Therapeutics, Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.65 - a 54.86% jump from last quarter’s estimates.

EPS Estimate Current Year:

Ptc Therapeutics, Inc.’s earning per share (EPS) estimates for the current year stand at -0.65.

Key Ratios

Key ratios of the Ptc Therapeutics, Inc. post its Q4 2024 earnings
Earning Per Share (EPS)
-0.34
Highlights
Earning Per Share (EPS):

Ptc Therapeutics, Inc.’s earning per share (EPS) fell -42.33% since last year same period to -0.34 in the Q4 2024. This indicates that the Ptc Therapeutics, Inc. has generated -42.33% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2024-11-07
-1.44
-1.39
3.47%
2024-04-25
-1.24
-1.2
3.23%
2025-02-27
-0.65
-0.34
47.45%
2024-08-08
-1.05
-1.27
-20.95%